Listed

SUI Group Holdings Ltd.: Form 10-Q for the period ended Sep 30, 2024

Filed with the SEC on Nov 12, 2024 and accepted by EDGAR at Nov 12, 2024, 07:57 ET.

Share

Management's discussion and analysis

As filed, 15,304 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is intended to provide a reader of our financial statements with a narrative from the perspective of management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results. In addition, unless expressly stated otherwise, the comparisons presented in this MD&A refer to the same period in the prior year. Our MD&A is presented in seven sections:

  • Overview
  • Portfolio and Investment Activity
  • Results of Operations
  • Financial Condition
  • Critical Accounting Estimates
  • Off-Balance Sheet Arrangements
  • Forward Looking Statements

OVERVIEW

Mill City Ventures III, Ltd. was incorporated in the State of Minnesota on January 10, 2006. In this report, we generally refer to Mill City Ventures III, Ltd. in the first person “we.” On occasion, we refer to our company in the third person as “Mill City Ventures” or the “company.”

We are engaged in the business of providing short-term non-bank lending and specialty finance solutions to companies and individuals, generally on a secured basis. The loans we provide typically have maturities that are nine months or shorter, highly illiquid, and ordinarily involve a pledge of collateral or, in the case of loans made to companies, personal guarantees by the principals of the borrower. Our loans may be made for real estate acquisitions, renovation and sale, or other projects relating to real estate, title loans, inventory needs, inventory financing, solve for short-term liquidity needs, or for other similar purposes. We intend to remain opportunistic, however, and may occasionally engage in transactions that involve our acquisition of other rights (such as stock, warrants or other equity-linked investments) or that are structured differently or uniquely. Our business objective is to generate revenues from the interest and fees we charge, and capital appreciation from any related investments we make.

Our principal sources of income are interest and fees associated with our loans such as origination fees, closing fees or exit fees. In connection with the short-term non-bank specialty finance loans we provide, we may receive reimbursement of legal costs associated with loan documentation. We occasionally derive income from dividends paid on equity securities we hold from time to time, or from the sale of our equity securities. Our statement of operations also reflect increases and decreases in the carrying value of our assets and investments (i.e., unrealized appreciation and depreciation). Our principal expenses relate to operating expenses, the largest components of which are generally professional fees, payroll, occupancy, and insurance expenses.

Our MD&A should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2023, as well as our reports on Forms 10-Q and 8-K and other publicly available information. All amounts herein are unaudited. In addition, the following discussion of our results of operations and financial condition should be read in the context of this overview.

18

Table of Contents

PORTFOLIO AND INVESTMENT ACTIVITY

During the nine months ended September 30, 2024, we made $5,106,503 of investment purchases and had $6,614,573 of redemptions and repayments, resulting in net investments at amortized cost of $17,208,066 at the end of the period.

During the nine months ended September 30, 2023, we made $11,900,500 of investment purchases and had $11,124,193 of redemptions and repayments, resulting in net investments at amortized cost of $17,577,481 at the end of that period.

Our portfolio composition by major class, based on fair value at September 30, 2024, was as follows:

Investments at Fair Value Percentage of Fair Value
Short-term Non-banking Loans $15,715,822 97.0%
Common Stock 492,243 3.0
Total $16,208,065 100.0%

RESULTS OF OPERATIONS

Our operating results for the three and nine months ended September 30, 2024 and September 30, 2023 were as follows:

For the Three Months Ended September 30, 2024 2023 For the Nine Months Ended September 30, 2024 2023
Investment Income: $711,022 $725,158 $2,432,318 $2,496,688
Operating Expenses: (419,847) (421,373) (1,178,993) (2,883,235)
Net Investment Gain (Loss) $291,175 $303,785 $1,253,325 $(386,547)

Investment Income

We generate revenue primarily in the form of interest income derived from the short-term non-banking loans we provide, together with fees we charge in connection with those loans, such as commitment, origination, structuring, diligence, or consulting fees. Any such fees will be recognized as earned. In some cases, the interest payable to us on the short-term loans we provide may accrue or be paid in the form of additional debt. The principal amount of the debt instruments, together with any accrued but unpaid interest thereon, will generally become due at the maturity date of those debt instruments. On occasion, we may also generate revenue from dividends and capital gains on equity investments we make, if any, or on warrants or other equity interests that we may acquire.

For the three and nine months ended September 30, 2024, our total investment income was 711,022 and $2,432,318, respectively. For the three and nine months ended September 30, 2023 our total investment income was $725,158 and $2,496,688, respectively. Our loan portfolio generates interest income, with an average rate on the loans of 16.2%.

Professional Fees

For the three and nine months ended September 30, 2024, we had $190,369 and $502,838 professional fees expense, respectively. For the three and nine months ended September 30, 2023, we had $184,008 and $601,184 professional fees expense, respectively. The decrease is due to the decrease in loan activity during the current year.

Payroll and Directors Fees

For the three and nine months ended September 30, 2024, we had $148,072 and $444,997 of payroll expense, respectively, and we had $30,000 and $90,000 of directors fees, respectively. For the three and nine months ended September 30, 2023, we had $141,040 and $1,418,640 of payroll expense, respectively, and we had $30,000 and $592,968 of directors fees, respectively. The increase in 2023 over 2024 is due to a stock option issuance recognized in January 2023.

19

Table of Contents

Interest Expense

For the three and nine months ended September 30, 2024, we had $0 and $320 of interest expense, respectively. For the three and nine months ended September 30, 2023, we had $0 and $78,000 of interest expense, respectively. The decrease is due to the termination of the line of credit agreement in January 2024.

Net Realized Gain (Loss) from Investments

For the three and nine months ended September 30, 2024, we had $5,152,682 and $6,614,573, respectively, of sales of investments resulting in $232,585 of realized losses and $138,655 of realized gains, respectively. For the three and nine months ended September 30, 2023, we had $0 and $94,569, respectively, of sales of investments resulting in $0 and $558,629 of realized losses, respectively.

Net Change in Unrealized Appreciation (Depreciation) on Investments

For the three and nine months ended September 30, 2024, our investments had $530,693 and $292,803 of unrealized appreciation, respectively. For the three and nine months ended September 30, 2023, our investments had $2,175 and $629,491 of unrealized appreciation, respectively.

Changes in Net Assets from Operations

For the three and nine months ended September 30, 2024, we recorded a net increase in net assets from operations of $463,783 and $1,258,822, respectively. Based on the weighted-average number of shares of common stock outstanding for the three and nine months ended September 30, 2024, our per-share net increase in net assets from operations was $0.07 and $0.20, respectively, before dilution, and $0.07 and $0.19, respectively, after dilution. For the three and nine months ended September 30, 2023, we recorded a net increase in net assets from operations of $369,560 and a net decrease in net assets from operations of $277,763, respectively. Based on the weighted-average number of shares of common stock outstanding for the three and nine months ended September 30, 2023, our per-share net increase in net assets from operations was $0.06 and our per share net decrease in net assets from operations was $0.04, respectively.

Cash Flows for the Nine Months Ended September 30, 2024 and 2023

The level of cash flows used in or provided by operating activities is affected primarily by our provision of short-term loans, purchases of other investments, redemptions and repayments of our loans or investments, and other related factors. For the nine months ended September 30, 2024, net cash provided in operating activities was $2,756,853. Cash flows provided in operating activities for the nine months ended September 30, 2024 were primarily related to the funding of our short-term loans and purchases of investments aggregating $5,106,503, offset mostly by redemptions and repayments of short-term loans and investments totaling $6,614,573. For the nine months ended September 30, 2023, net cash used in operating activities was $550,781. Cash flows used in operating activities for the nine months ended September 30, 2023 were primarily related to the funding of our short-term loans and purchases of investments aggregating $11,900,500, offset mostly by redemptions and repayments of short-term loans and investments totaling $11,124,193.

FINANCIAL CONDITION

As of September 30, 2024, we had cash and cash equivalents of $3,132,877, an increase of $2,756,853 from December 31, 2023. The primary use of our existing funds and any funds raised in the future is expected to be for our investments in portfolio companies or for other general corporate purposes, including paying for operating expenses or debt service to the extent we borrow or issue senior securities. Pending investment in portfolio companies, our investments may consist of cash, cash equivalents, U.S. government securities or high-quality debt securities maturing in one year or less from the time of investment, which we refer to collectively as “temporary investments.”

CRITICAL ACCOUNTING ESTIMATES

Our financial statements are prepared in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Critical accounting policies are those that require the application of management’s most difficult, subjective or complex judgments, often because of the need to make estimates about the effect of matters that are inherently uncertain and that may change in subsequent periods.

In preparing the financial statements, management will make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. In preparing the financial statements, management also will utilize available information, including our past history, industry standards and the current economic environment, among other factors, in forming its estimates and judgments, giving due consideration to materiality. Actual results will almost certainly differ from these estimates. In addition, other companies may utilize different estimates, which may impact the comparability of our results of operations to those of companies in similar businesses. As our expected operating results occur, we will describe additional critical accounting policies in the notes to our financial statements. Our most critical accounting policies relate to the valuation of our portfolio investments, and revenue recognition. For more information, refer to our Annual Report on Form 10-K for the year ended December 31, 2023.

20

Table of Contents

OFF-BALANCE-SHEET ARRANGEMENTS

During the nine months ended September 30, 2024, we did not engage in any off-balance sheet arrangements as described in Item 303(a)(4) of Regulation S-K.

FORWARD-LOOKING STATEMENTS

Some of the statements made in this section of our report are forward-looking statements based on our management’s current expectations for our company. These expectations involve assumptions and are subject to substantial risks and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. Forward-looking statements relate to future events or our future financial performance, and can ordinarily be identified by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar words. Important assumptions include our ability to identify and consummate new investments, achieve certain margins and levels of profitability, the availability of any needed additional capital, and the ability to maintain compliance with regulations applicable to us. Some of the forward-looking statements contained in this report relate to, and are based our current assumptions regarding, the following:

  • our future operating results;
  • the success of our investments;
  • our relationships with third parties;
  • the dependence of our success on the general economy and its impact on the industries in which we invest;
  • the ability of our portfolio companies to achieve their objectives;
  • our expected financings and investments;
  • our regulatory structure and tax treatment;
  • the adequacy of our cash resources and working capital; and
  • the timing of cash flows, if any, we receive from our investments.

The foregoing list is not exhaustive. For a more complete summary of the risks and uncertainties facing our company and its business and relating to our forward-looking statements, please refer to our Annual Report on Form 10-K filed on April 2, 2024 (related to our year ended December 31, 2023) and in particular the section thereof entitled “Risk Factors.” Because of the significant uncertainties inherent in forward-looking statements pertaining to our company, the inclusion of those statements should not be regarded as a representation or warranty by us or any other person that our objectives, plans, expectations or projections that are contained in this filing will be achieved in any specified time frame, if ever. We undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date of this filing. The forward-looking statements made in this report relate only to events as of the date on which the statements are made, and are excluded from the safe harbor protection provided by Section 21E of the Securities Exchange Act of 1934.

Controls and procedures

As filed, 1,570 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We maintain disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in our reports filed pursuant to the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance the objectives of the control system are met.

As of September 30, 2024, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of our disclosure controls and procedures as such term is defined in Rule 13a-15(e) under the Securities and Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded our disclosure controls and procedures were not effective as of September 30, 2024 due to the material weakness in our internal control over financial reporting identified and disclosed in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2023.

There were no significant changes in our internal controls over financial reporting that occurred during the fiscal quarter covered by this report that materially affected, or were reasonably likely to materially affect such controls.

21

Table of Contents

Risk factors

As filed, 3,640 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company is updating its risk factors with the following risk factor disclosure:

Our $10 million loan to Mustang Funding is subordinated to senior lenders both in right of payment and in respect of our exercise of rights and remedies, with the result that our investment portfolio and related results of operations will, for the foreseeable future, be highly concentrated in and dependent upon the operational and financing success of Mustang Funding.

On December 12, 2022, contemporaneously with our entry into a non-binding letter of intent with Mustang Funding, LLC (“Mustang”) contemplating a combination or merger transaction, we entered into a lending agreement with Mustang pursuant to which we loaned Mustang the principal amount of $5 million maturing in September 2023. Among other things, our related loan agreement with Mustang requires us to consent to any additional indebtedness Mustang may incur, subject to certain limitations and exceptions.

On December 28, 2022, we entered into a subordination agreement with Orion Pip LLC, as administrative and collateral agent for itself and other senior lenders under a senior secured lending agreement (collectively, the “Senior Lenders”), pursuant to which we subordinated our right to payment, subject to certain exceptions, and our right to exercise rights and remedies, to Mustang’s prior repayment in full of amounts owing to the Senior Lenders. The subordination agreement prohibits the Senior Lenders or Mustang from extending the stated maturity of amounts owing under the senior secured lending agreement beyond December 2026. We have been advised that the Senior Lenders are owed $15.675 million in principal amount under the senior secured lending agreement.

In June, August and September 2023, we advanced additional principal to Mustang as we continued working with them on a potential definitive merger agreement and related deliverables. These additional principal advances resulted in aggregate loan principal of $10 million. In connection with these advances, the maturity date of our loan was extended to June 2024. In April 2024, we agreed to a final extension of the maturity date to the earlier of December 31, 2024, or 90 days after the termination of negotiations for our combination transaction with Mustang.

On August 20, 2024, we terminated the non-binding letter of intent with Mustang. As a result, amounts owing under our $10 million loan to Mustang were to mature on November 18, 2024. Nevertheless, the subordination agreement with the Senior Lenders effectively means that, unless Mustang has free cash flow from operations or other sources of cash permitted under the subordination agreement, we will likely be unable to collect the principal amount until the Senior Lenders are repaid.

Presently and for the foreseeable future, we expect that we will receive interest payments as required by our loan agreement with Mustang. The per annum rate of interest for our loan to Mustang is 15%, subject to automatic increase to 25% in the event of a default by Mustang in the payment of interest or principal as required under the loan agreement. Because of this and for other reasons, we presently expect that Mustang may approach us to formalize one or more extensions of our maturity date. We do not expect, however, to consent to any proposal by Mustang to incur additional senior indebtedness not permitted by the agreements to which we are party; and in the event that such indebtedness is incurred in violation of those agreements, we would expect to pursue all legal and equitable remedies available to us.

17

Table of Contents

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Interest expense3 months2024-07-01 to 2024-09-30$0us-gaap:InterestExpense
Interest expense9 months2024-01-01 to 2024-09-30$320us-gaap:InterestExpense
Income tax3 months2024-07-01 to 2024-09-30$125.5kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2024-01-01 to 2024-09-30$426.0kus-gaap:IncomeTaxExpenseBenefit
Diluted EPS3 months2024-07-01 to 2024-09-30$0.07us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2024-01-01 to 2024-09-30$0.19us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-07-01 to 2024-09-30$0.07us-gaap:EarningsPerShareBasic
Basic EPS9 months2024-01-01 to 2024-09-30$0.20us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-07-01 to 2024-09-306,501,823 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2024-01-01 to 2024-09-306,501,823 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2024-01-01 to 2024-09-30$2.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Total assetsAt period end2024-09-30$20.3mus-gaap:Assets
Total liabilitiesAt period end2024-09-30$491.0kus-gaap:Liabilities
Shareholders' equityAt period end2024-09-30$19.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001654954-24-014099. Last ingested by Listed: Nov 13, 2026, 14:38 ET. Listed shows no prices and gives no investment advice.